BIOLASE, Inc. (BIOL)
USD 0.02
(27.39%)
USD 0.02
(27.39%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -20.63 Million USD | 27.95% |
| 2022 | -28.63 Million USD | -77.21% |
| 2021 | -16.15 Million USD | 3.99% |
| 2020 | -16.82 Million USD | 5.75% |
| 2019 | -17.85 Million USD | 17.02% |
| 2018 | -21.51 Million USD | -27.68% |
| 2017 | -16.85 Million USD | -9.63% |
| 2016 | -15.37 Million USD | 24.2% |
| 2015 | -20.27 Million USD | -7.14% |
| 2014 | -18.92 Million USD | -64.83% |
| 2013 | -11.48 Million USD | -275.72% |
| 2012 | -3.05 Million USD | 31.88% |
| 2011 | -4.48 Million USD | 62.68% |
| 2010 | -12.02 Million USD | -306.66% |
| 2009 | -2.95 Million USD | 67.62% |
| 2008 | -9.12 Million USD | -25.4% |
| 2007 | -7.28 Million USD | -55.26% |
| 2006 | -4.68 Million USD | 73.22% |
| 2005 | -17.51 Million USD | 24.57% |
| 2004 | -23.21 Million USD | -221.81% |
| 2003 | 19.05 Million USD | 624.64% |
| 2002 | 2.63 Million USD | 744.61% |
| 2001 | -408 Thousand USD | 89.06% |
| 2000 | -3.72 Million USD | 22.29% |
| 1999 | -4.79 Million USD | 53.43% |
| 1998 | -10.3 Million USD | -267.86% |
| 1997 | -2.8 Million USD | -12.0% |
| 1996 | -2.5 Million USD | -25.0% |
| 1995 | -2 Million USD | 35.48% |
| 1994 | -3.1 Million USD | 58.67% |
| 1993 | -7.5 Million USD | -36.36% |
| 1992 | -5.5 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -6.48 Million USD | -21.76% |
| 2024 Q2 | -2.79 Million USD | 56.85% |
| 2023 Q3 | -4.58 Million USD | 5.73% |
| 2023 Q1 | -5.84 Million USD | 40.69% |
| 2023 Q4 | -5.32 Million USD | -16.06% |
| 2023 FY | -20.63 Million USD | 27.95% |
| 2023 Q2 | -4.86 Million USD | 16.77% |
| 2022 Q2 | -5.61 Million USD | -17.48% |
| 2022 Q4 | -9.86 Million USD | -17.57% |
| 2022 FY | -28.63 Million USD | -77.21% |
| 2022 Q3 | -8.38 Million USD | -49.47% |
| 2022 Q1 | -4.77 Million USD | 9.53% |
| 2021 Q3 | -3.27 Million USD | -366.67% |
| 2021 Q4 | -5.27 Million USD | -61.14% |
| 2021 FY | -16.15 Million USD | 3.99% |
| 2021 Q1 | -6.9 Million USD | -12.36% |
| 2021 Q2 | -702 Thousand USD | 89.83% |
| 2020 Q3 | 12 Thousand USD | 100.26% |
| 2020 Q2 | -4.69 Million USD | 21.79% |
| 2020 Q1 | -6 Million USD | -68.33% |
| 2020 FY | -16.82 Million USD | 5.75% |
| 2020 Q4 | -6.14 Million USD | -51283.33% |
| 2019 Q4 | -3.56 Million USD | 34.87% |
| 2019 FY | -17.85 Million USD | 17.02% |
| 2019 Q2 | -3.89 Million USD | 20.43% |
| 2019 Q1 | -4.9 Million USD | 29.18% |
| 2019 Q3 | -5.47 Million USD | -40.5% |
| 2018 Q1 | -5.02 Million USD | -30.69% |
| 2018 FY | -21.51 Million USD | -27.68% |
| 2018 Q4 | -6.91 Million USD | -48.32% |
| 2018 Q3 | -4.66 Million USD | 5.01% |
| 2018 Q2 | -4.91 Million USD | 2.19% |
| 2017 Q1 | -4.1 Million USD | 7.21% |
| 2017 Q3 | -4.61 Million USD | -7.53% |
| 2017 Q4 | -3.84 Million USD | 16.7% |
| 2017 FY | -16.85 Million USD | -9.63% |
| 2017 Q2 | -4.28 Million USD | -4.41% |
| 2016 FY | -15.37 Million USD | 24.2% |
| 2016 Q4 | -4.42 Million USD | -40.72% |
| 2016 Q3 | -3.14 Million USD | 10.95% |
| 2016 Q2 | -3.53 Million USD | 17.16% |
| 2016 Q1 | -4.26 Million USD | -73.52% |
| 2015 Q3 | -5.34 Million USD | 24.12% |
| 2015 Q4 | -2.45 Million USD | 54.0% |
| 2015 FY | -20.27 Million USD | -7.14% |
| 2015 Q2 | -7.04 Million USD | -29.53% |
| 2015 Q1 | -5.43 Million USD | -32.46% |
| 2014 FY | -18.92 Million USD | -64.83% |
| 2014 Q2 | -6.43 Million USD | -31.76% |
| 2014 Q3 | -3.49 Million USD | 45.72% |
| 2014 Q4 | -4.1 Million USD | -17.42% |
| 2014 Q1 | -4.88 Million USD | -118.76% |
| 2013 Q4 | -2.23 Million USD | 44.83% |
| 2013 Q3 | -4.04 Million USD | -57.67% |
| 2013 Q2 | -2.56 Million USD | 2.39% |
| 2013 Q1 | -2.63 Million USD | -352.74% |
| 2013 FY | -11.48 Million USD | -275.72% |
| 2012 FY | -3.05 Million USD | 31.88% |
| 2012 Q4 | 1.04 Million USD | 289.96% |
| 2012 Q3 | -548 Thousand USD | 70.8% |
| 2012 Q2 | -1.87 Million USD | -12.26% |
| 2012 Q1 | -1.67 Million USD | 17.64% |
| 2011 Q1 | -750 Thousand USD | -531.03% |
| 2011 Q2 | -753 Thousand USD | -0.4% |
| 2011 Q3 | -953 Thousand USD | -26.56% |
| 2011 Q4 | -2.03 Million USD | -113.01% |
| 2011 FY | -4.48 Million USD | 62.68% |
| 2010 Q3 | -2.72 Million USD | 34.53% |
| 2010 Q4 | 174 Thousand USD | 106.38% |
| 2010 Q1 | -5.3 Million USD | -261.13% |
| 2010 FY | -12.02 Million USD | -306.66% |
| 2010 Q2 | -4.16 Million USD | 21.51% |
| 2009 Q4 | -1.46 Million USD | -271.01% |
| 2009 Q2 | 2.33 Million USD | 149.83% |
| 2009 FY | -2.95 Million USD | 67.62% |
| 2009 Q3 | 859 Thousand USD | -63.13% |
| 2009 Q1 | -4.67 Million USD | 11.56% |
| 2008 Q2 | 622 Thousand USD | 2292.31% |
| 2008 Q1 | 26 Thousand USD | 102.26% |
| 2008 Q3 | -4.49 Million USD | -821.86% |
| 2008 FY | -9.12 Million USD | -25.4% |
| 2008 Q4 | -5.28 Million USD | -17.75% |
| 2007 Q3 | -3.5 Million USD | -289.35% |
| 2007 FY | -7.28 Million USD | -55.26% |
| 2007 Q2 | -901 Thousand USD | 47.71% |
| 2007 Q1 | -1.72 Million USD | -265.99% |
| 2007 Q4 | -1.14 Million USD | 67.27% |
| 2006 Q1 | -2.28 Million USD | -86.3% |
| 2006 FY | -4.68 Million USD | 73.22% |
| 2006 Q3 | -1 Million USD | 58.66% |
| 2006 Q4 | 1.03 Million USD | 203.08% |
| 2006 Q2 | -2.43 Million USD | -6.65% |
| 2005 FY | -17.51 Million USD | 24.57% |
| 2005 Q4 | -1.22 Million USD | 76.56% |
| 2005 Q3 | -5.23 Million USD | 22.84% |
| 2005 Q2 | -6.77 Million USD | -58.61% |
| 2005 Q1 | -4.27 Million USD | 81.71% |
| 2004 FY | -23.21 Million USD | -221.81% |
| 2004 Q3 | -1.23 Million USD | -272.21% |
| 2004 Q1 | 672 Thousand USD | -95.3% |
| 2004 Q2 | 716 Thousand USD | 6.55% |
| 2004 Q4 | -23.36 Million USD | -1795.3% |
| 2003 FY | 19.05 Million USD | 624.64% |
| 2003 Q2 | 1.25 Million USD | 85.91% |
| 2003 Q1 | 674 Thousand USD | -37.01% |
| 2003 Q3 | 2.56 Million USD | 104.87% |
| 2003 Q4 | 14.29 Million USD | 456.99% |
| 2002 Q2 | 669 Thousand USD | 462.18% |
| 2002 Q4 | 1.07 Million USD | 38.6% |
| 2002 Q1 | 119 Thousand USD | -70.98% |
| 2002 Q3 | 772 Thousand USD | 15.4% |
| 2002 FY | 2.63 Million USD | 744.61% |
| 2001 FY | -408 Thousand USD | 89.06% |
| 2001 Q3 | 102 Thousand USD | 169.17% |
| 2001 Q1 | -772.4 Thousand USD | -20.05% |
| 2001 Q2 | -147.46 Thousand USD | 80.91% |
| 2001 Q4 | 410 Thousand USD | 301.96% |
| 2000 Q1 | -1.03 Million USD | 48.32% |
| 2000 Q4 | -643.39 Thousand USD | 44.76% |
| 2000 FY | -3.72 Million USD | 22.29% |
| 2000 Q3 | -1.16 Million USD | -31.19% |
| 2000 Q2 | -887.77 Thousand USD | 13.98% |
| 1999 FY | -4.79 Million USD | 53.43% |
| 1999 Q1 | -700 Thousand USD | 56.25% |
| 1999 Q2 | -1.2 Million USD | -71.43% |
| 1999 Q3 | -900 Thousand USD | 25.0% |
| 1999 Q4 | -1.99 Million USD | -121.9% |
| 1998 Q1 | -800 Thousand USD | 0.0% |
| 1998 FY | -10.3 Million USD | -267.86% |
| 1998 Q2 | -1.2 Million USD | -50.0% |
| 1998 Q3 | -6.7 Million USD | -458.33% |
| 1998 Q4 | -1.6 Million USD | 76.12% |
| 1997 Q1 | -800 Thousand USD | 0.0% |
| 1997 FY | -2.8 Million USD | -12.0% |
| 1997 Q4 | -800 Thousand USD | -60.0% |
| 1997 Q3 | -500 Thousand USD | 28.57% |
| 1997 Q2 | -700 Thousand USD | 12.5% |
| 1996 Q2 | -600 Thousand USD | -20.0% |
| 1996 Q1 | -500 Thousand USD | 16.67% |
| 1996 FY | -2.5 Million USD | -25.0% |
| 1996 Q4 | -800 Thousand USD | -33.33% |
| 1996 Q3 | -600 Thousand USD | 0.0% |
| 1995 Q4 | -600 Thousand USD | -100.0% |
| 1995 Q2 | -400 Thousand USD | 50.0% |
| 1995 Q1 | -800 Thousand USD | 50.0% |
| 1995 Q3 | -300 Thousand USD | 25.0% |
| 1995 FY | -2 Million USD | 35.48% |
| 1994 Q2 | -500 Thousand USD | -150.0% |
| 1994 Q4 | -1.6 Million USD | -100.0% |
| 1994 Q3 | -800 Thousand USD | -60.0% |
| 1994 Q1 | -200 Thousand USD | 91.67% |
| 1994 FY | -3.1 Million USD | 58.67% |
| 1993 Q4 | -2.4 Million USD | -50.0% |
| 1993 FY | -7.5 Million USD | -36.36% |
| 1993 Q3 | -1.6 Million USD | 15.79% |
| 1993 Q2 | -1.9 Million USD | -18.75% |
| 1993 Q1 | -1.6 Million USD | 30.43% |
| 1992 FY | -5.5 Million USD | 0.0% |
| 1992 Q4 | -2.3 Million USD | -155.56% |
| 1992 Q2 | -1.2 Million USD | 0.0% |
| 1992 Q3 | -900 Thousand USD | 25.0% |
| 1992 Q1 | -1.2 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 66.516% |
| BrainsWay Ltd. | -4.19 Million USD | -391.589% |
| Cerus Corporation | -37.48 Million USD | 44.965% |
| Envoy Medical, Inc. | -29.9 Million USD | 31.015% |
| electroCore, Inc. | -18.83 Million USD | -9.547% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -133.13% |
| IceCure Medical Ltd | -14.65 Million USD | -40.814% |
| Inogen, Inc. | -102.44 Million USD | 79.861% |
| OrthoPediatrics Corp. | -20.97 Million USD | 1.631% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 60.825% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -50.103% |
| MaxCyte, Inc. | -37.92 Million USD | 45.595% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -73.97% |
| Nexalin Technology, Inc. | -4.64 Million USD | -343.822% |
| Orthofix Medical Inc. | -151.39 Million USD | 86.372% |
| PAVmed Inc | -64.17 Million USD | 67.85% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 60.676% |
| RxSight, Inc. | -48.6 Million USD | 57.554% |
| Sight Sciences, Inc. | -55.54 Million USD | 62.857% |
| SI-BONE, Inc. | -43.33 Million USD | 52.391% |
| TELA Bio, Inc. | -46.66 Million USD | 55.786% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 58.342% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -51.896% |
| Acutus Medical, Inc. | -81.66 Million USD | 74.735% |
| Talis Biomedical Corporation | -62 Million USD | 66.726% |
| Spectral AI, Inc. | -20.85 Million USD | 1.065% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 66.052% |
| CVRx, Inc. | -41.19 Million USD | 49.921% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 3322.763% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -88.329% |
| Bioventus Inc. | -156.23 Million USD | 86.794% |
| Venus Concept Inc. | -37.25 Million USD | 44.612% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 65.053% |
| LivaNova PLC | 17.54 Million USD | 217.588% |
| 908 Devices Inc. | -36.39 Million USD | 43.317% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 88.945% |
| Nemaura Medical Inc. | -14.14 Million USD | -45.874% |
| NeuroPace, Inc. | -32.95 Million USD | 37.395% |
| LENSAR, Inc. | -14.38 Million USD | -43.447% |
| Apyx Medical Corporation | -18.71 Million USD | -10.255% |
| Cutera, Inc. | -162.83 Million USD | 87.329% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -90.508% |
| BioSig Technologies, Inc. | -29.04 Million USD | 28.956% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 75.042% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 6.596% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 130.457% |
| Axonics, Inc. | -6.08 Million USD | -238.896% |
| Outset Medical, Inc. | -172.79 Million USD | 88.06% |
| IRIDEX Corporation | -9.57 Million USD | -115.59% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 80.517% |
| IRadimed Corporation | 17.19 Million USD | 220.004% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -150.267% |
| INVO Bioscience, Inc. | -8.03 Million USD | -156.789% |
| Telesis Bio, Inc. | -47.72 Million USD | 56.768% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 301.425% |
| Varex Imaging Corporation | -47.7 Million USD | 56.746% |
| Quipt Home Medical Corp. | -2.78 Million USD | -641.092% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -82.811% |
| Pulmonx Corporation | -60.84 Million USD | 66.09% |
| Dynatronics Corporation | -2.69 Million USD | -664.794% |
| Modular Medical, Inc. | -17.47 Million USD | -18.1% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -81.189% |
| Semler Scientific, Inc. | 20.58 Million USD | 200.238% |
| InMode Ltd. | 197.91 Million USD | 110.424% |
| Bruker Corporation | 427.2 Million USD | 104.83% |
| Cytosorbents Corporation | -28.5 Million USD | 27.626% |
| DexCom, Inc. | 541.5 Million USD | 103.81% |
| Align Technology, Inc. | 445.05 Million USD | 104.636% |
| Viveve Medical, Inc. | -22.02 Million USD | 6.333% |
| ZimVie Inc. | -393.28 Million USD | 94.754% |
| Movano Inc. | -29.28 Million USD | 29.543% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -69.839% |
| Nexalin Technology, Inc. | -4.64 Million USD | -343.822% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 3322.763% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 90.732% |
| Profound Medical Corp. | -28.56 Million USD | 27.782% |
| Insulet Corporation | 206.3 Million USD | 110.001% |
| enVVeno Medical Corporation | -23.51 Million USD | 12.264% |
| Surmodics, Inc. | -11.54 Million USD | -78.756% |
| iCAD, Inc. | -4.84 Million USD | -325.665% |
| Nuwellis, Inc. | -20.2 Million USD | -2.093% |
| Biotricity, Inc. | -14.09 Million USD | -46.386% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 83.281% |
| Aethlon Medical, Inc. | -12.2 Million USD | -69.002% |
| InspireMD, Inc. | -19.91 Million USD | -3.595% |
| PAVmed Inc. | -64.17 Million USD | 67.85% |
| Beyond Air, Inc. | -60.24 Million USD | 65.751% |
| FONAR Corporation | 10.56 Million USD | 295.242% |
| AxoGen, Inc. | -21.71 Million USD | 4.992% |
| Vivani Medical, Inc. | -25.65 Million USD | 19.57% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 172.355% |
| Inari Medical, Inc. | -1.63 Million USD | -1161.125% |
| UFP Technologies, Inc. | 44.92 Million USD | 145.926% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -302.0% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -212.36% |
| Tenon Medical, Inc. | -15.58 Million USD | -32.418% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -33.748% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 41.607% |
| AdaptHealth Corp. | -678.89 Million USD | 96.961% |
| Sintx Technologies, Inc. | -8.25 Million USD | -149.812% |
| NanoVibronix, Inc. | -3.71 Million USD | -455.969% |
| Quanterix Corporation | -32.33 Million USD | 36.191% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -82.811% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 4354.021% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 93.274% |
| TransMedics Group, Inc. | -25.02 Million USD | 17.564% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 6.782% |
| NeuroMetrix, Inc. | -6.52 Million USD | -215.982% |
| Hyperfine, Inc. | -44.23 Million USD | 53.361% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 73.718% |
| Biomerica, Inc. | -5.97 Million USD | -245.132% |
| Bone Biologics Corporation | -8.94 Million USD | -130.558% |
| AVITA Medical, Inc. | -39.16 Million USD | 47.325% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -107.276% |
| Silk Road Medical, Inc | -55.74 Million USD | 62.987% |